1. Introduction

Biometric Fertility Screening refers to the use of biological measurements, physiological indicators, genetic information, or biometric technologies to assess, predict, or classify a person's reproductive health or potential fertility.

It is an interdisciplinary subject involving medical law, constitutional law, reproductive rights, privacy, data protection, bioethics, equality, and artificial intelligence regulation.

The term does not describe one universally recognised legal doctrine. Rather, it identifies a range of practices whose legality depends on the purpose of screening, the scientific validity of the method, the individual's consent, the sensitivity of the information collected, and the consequences of the screening results.

For example, a fertility clinic might use hormone measurements and ultrasound findings to assess ovarian function. A research programme might examine genetic variants associated with inherited reproductive conditions. A digital health system might combine menstrual-cycle data, heart-rate measurements, and other physiological indicators to estimate fertile periods.

These examples must be distinguished from systems that use fingerprints, facial recognition, iris scans, or other identity biometrics to identify people and then link them to fertility records. Identity biometrics do not, by themselves, establish whether a person is fertile or infertile.

The central legal question is:

When does fertility screening become an unjustified intrusion into bodily autonomy, reproductive choice, privacy, or equality?

In India, the constitutional principles established by the Supreme Court in Justice K.S. Puttaswamy v. Union of India and Suchita Srivastava v. Chandigarh Administration provide particularly important foundations for answering this question.

Indian Kanoon+1

2. Meaning and scope of biometric fertility screening

The expression can cover several distinct technologies and practices.

A. Physiological and hormonal screening

Testing hormone levels, including anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and other clinically relevant markers, alongside ultrasound examinations or semen analysis.

Legal issue: Whether testing is medically justified, accurately explained, voluntary where required, and used only for an appropriate clinical purpose.

B. Genetic and genomic screening

Analysis of genetic variants associated with inherited conditions, reproductive disorders, or particular risks relevant to conception and pregnancy.

Legal issue: Genetic privacy, informed consent, the handling of family information, discrimination, and the distinction between disease-risk assessment and selecting supposedly desirable characteristics.

C. Digital and algorithmic fertility assessment

Software combines cycle records, temperature, wearable sensor readings, and other health information to estimate ovulation or fertile windows.

Legal issue: Accuracy, explainability, data security, consent to secondary use, and liability when an unreliable prediction causes harm.

D. Identity biometrics linked to fertility records

Fingerprints, facial images, iris scans, or other identifiers may be used to connect a patient to medical records or fertility services.

Legal issue: Whether the collection and linkage are necessary, proportionate, secure, and authorised. Identity verification is not itself a fertility test.

A crucial medical distinction is that a biomarker associated with reproductive function does not necessarily prove that someone is fertile or infertile. For example, AMH can help assess ovarian reserve, but it cannot independently establish whether a person will conceive naturally. Legal decisions based on screening must therefore take account of the limits of the underlying science.

3. Legal framework in India

A. Constitutional protection under Article 21

Article 21 of the Constitution of India protects life and personal liberty. Supreme Court jurisprudence interprets this protection to include privacy, dignity, bodily integrity, and reproductive decision-making.

A compulsory fertility examination, the unauthorised disclosure of fertility results, or a decision to exclude someone from an opportunity because of an unverified fertility prediction may raise constitutional questions.

Where government bodies or public institutions are involved, Articles 14 and 21 are particularly important. Article 14 protects equality before the law and equal protection of the laws.

B. Reproductive autonomy

Reproductive autonomy includes the freedom to make decisions about whether to have children, whether to undergo fertility treatment, and whether to participate in reproductive medical procedures.

This principle protects both the choice to reproduce and the choice not to reproduce. It does not mean that every requested fertility treatment must automatically be provided regardless of lawful eligibility requirements or medical considerations.

C. Data protection and medical confidentiality

Fertility records can disclose intimate information about a person's physical health, reproductive plans, genetic characteristics, relationships, and family circumstances.

The relevant Indian legal analysis may involve:

The Digital Personal Data Protection Act, 2023, subject to its applicable commencement provisions and rules.

Professional duties of medical confidentiality and informed consent.

The Information Technology Act, 2000, and applicable rules where relevant to the particular processing or disclosure.

Constitutional privacy protections where the State or public authorities are involved.

Applicable assisted-reproduction legislation and regulations.

The precise obligations depend on the institution, the data involved, the purpose of collection, the applicable statutory provisions, and any relevant exemptions. A clinic should not assume that consent to a medical test also authorises unrestricted sharing with employers, insurers, advertisers, or unrelated research organisations.

D. Assisted Reproductive Technology (Regulation) Act, 2021

The Assisted Reproductive Technology (Regulation) Act, 2021 is directly relevant when fertility screening occurs in an assisted-reproduction clinic or is connected with donor gametes, embryos, or fertility treatment.

Three provisions are especially important:

Section 21: Establishes duties of ART clinics and banks, including counselling, confidentiality, and specified medical testing of donors.

Section 22: Requires written informed consent for ART treatment and procedures, with additional provisions governing reproductive material and withdrawal of consent.

Section 23: Requires clinics and banks to maintain accurate records.

Indian Kanoon+2

These provisions do not create an unrestricted power to screen every person's fertility. A clinic must distinguish between medically relevant testing, legally required donor screening, optional predictive assessments, and screening undertaken for unrelated purposes.

4. Important case laws

The following judgments establish principles that can be applied to fertility screening. Some concern reproductive autonomy directly; others concern privacy, pregnancy disclosure, assisted reproduction, or genetic selection. They should not be misrepresented as cases that specifically decided the legality of a modern biometric fertility-screening system.

Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

Facts and issue: A nine-judge Constitution Bench considered whether privacy is protected as a fundamental right under the Indian Constitution in litigation concerning the Aadhaar scheme.

Decision: The Court unanimously recognised privacy as a constitutionally protected right, grounded in liberty and dignity, including under Article 21. The judgment also recognised the importance of personal choice in intimate matters, including marriage, family, and procreation.

Indian Kanoon+1

Application to fertility screening:

A person's fertility information is closely connected with bodily integrity and intimate personal decisions.

Collecting biometric or physiological data without adequate legal justification may raise privacy concerns.

Linking fertility results with identity records requires careful consideration of purpose, necessity, security, and proportionality.

Government-mandated fertility screening cannot be justified merely by asserting administrative convenience.

Legal principle: Fertility-related data collection and use must be assessed consistently with constitutional privacy and autonomy, particularly where public authorities are involved.

Case 2: Suchita Srivastava v. Chandigarh Administration (2009)

Supreme Court of India · (2009) 9 SCC 1

Facts: The case concerned a woman with an intellectual disability who was living in a government institution and whose pregnancy had become the subject of a proposed termination. The question involved her reproductive rights and the legal requirements governing termination of pregnancy.

Decision: The Supreme Court recognised that reproductive choice is an aspect of personal liberty under Article 21. It explained that reproductive autonomy includes the right to procreate as well as the right to abstain from procreation.

eCourtsIndia+1

Application to fertility screening:

A person's fertility status should not automatically determine whether that person is entitled to make reproductive decisions.

Medical professionals should distinguish between providing information and imposing a reproductive decision.

Screening results should not be used to coerce sterilisation, pregnancy, fertility treatment, or the abandonment of reproductive plans.

Consent and decision-making capacity must be assessed in accordance with applicable law rather than assumed from a disability or diagnosis.

Legal principle: Fertility screening should support informed reproductive choices, not replace the individual's legally protected autonomy.

Case 3: K.S. Puttaswamy v. Union of India (Aadhaar judgment, 2018)

Supreme Court of India · (2019) 1 SCC 1

Facts and issue: The Court examined the constitutionality of Aadhaar and related questions about compulsory biometric identification, authentication, and the use of personal information.

Decision: The Court upheld parts of the Aadhaar framework while invalidating or restricting particular aspects. The separate opinions and the majority's reasoning must be read in context; the judgment does not establish that all biometric collection is either lawful or unlawful.

VoxJuris+1

Application to fertility screening:

The judgment is relevant where fingerprints, iris scans, or other identity data are used to connect a person with fertility records. It supports scrutiny of:

The legal basis for collecting biometric identifiers.

The purposes for which authentication data may be used.

The safeguards against unnecessary collection, retention, and disclosure.

The consequences of making access to a service conditional on biometric authentication.

A further distinction is essential: Aadhaar identity biometrics are not equivalent to medical fertility biomarkers. The constitutional analysis depends on what data are collected and how they are used.

Case 4: Neera Mathur v. Life Insurance Corporation of India (1992)

Supreme Court of India · (1992) 1 SCC 286

Facts: A woman employed by the Life Insurance Corporation of India faced termination after issues arose concerning information she had been required to disclose about pregnancy and menstruation.

Decision: The Supreme Court set aside her discharge and criticised intrusive demands for intimate reproductive information in the employment context.

LII / Legal Information Institute

Application to fertility screening:

This case is important when employers require fertility tests or demand reproductive-health disclosures as a condition of recruitment, continued employment, promotion, or workplace benefits.

For example, an employer's demand that every woman disclose her ovarian reserve, menstrual history, or fertility prognosis would raise serious concerns about privacy, equality, and the relevance of the information to the job.

The case does not establish a blanket prohibition on every occupational medical examination. The legal analysis depends on the purpose of the examination, the applicable employment law, the nature of the job, and the intrusiveness of the information demanded.

Legal principle: An employer's interest in administrative information does not automatically justify intrusive disclosure of an employee's reproductive life.

Case 5: Evans v. United Kingdom (2007)

European Court of Human Rights · Application No. 6339/05

Facts: After medical treatment for ovarian tumours, the applicant relied on embryos created using her eggs and her former partner's sperm. UK legislation permitted either party to withdraw consent before the embryos were used.

Decision: The Grand Chamber found no violation of Article 8 of the European Convention on Human Rights. It accepted that the case involved private life and the decision to become a genetic parent, while giving weight to the legal framework requiring continuing consent from both genetic contributors.

Bailii+1

Application to fertility screening:

This judgment demonstrates that reproductive autonomy may involve competing rights and lawful consent requirements. Fertility screening, particularly when linked to IVF or embryo-related decisions, must therefore be distinguished from decisions that independently determine how reproductive material may be used.

A favourable screening result does not itself establish consent to treatment, embryo creation, storage, or transfer.

Legal principle: Reproductive decision-making must respect the applicable consent framework and the rights of the people involved.

Case 6: Costa and Pavan v. Italy (2012)

European Court of Human Rights · Application No. 54270/10 · Judgment of 28 August 2012

Facts: A couple who were healthy carriers of cystic fibrosis challenged Italian restrictions preventing them from accessing preimplantation genetic diagnosis in their circumstances.

Decision: The Court found a violation of Article 8, considering the inconsistency between the restrictions on preimplantation genetic diagnosis and the availability of prenatal diagnosis followed by possible termination of pregnancy.

HUDOC+1

Application to fertility screening:

This case illustrates the distinction between screening intended to identify a serious inherited disease and screening intended to rank people according to supposed reproductive desirability.

It is relevant to questions about:

Genetic screening before assisted reproduction.

Access to reproductive technologies.

Proportionate restrictions on genetic testing.

The risks of arbitrary or inconsistent reproductive-health policies.

The judgment does not establish an unlimited right to choose embryos based on any genetic characteristic. Its reasoning concerned the particular legal restrictions and circumstances before the Court.

Case 7: A.K. v. Latvia (2014)

European Court of Human Rights · Application No. 33011/08

The case concerned a complaint about failure to provide timely prenatal screening, including an AFP test, to identify a risk of trisomy 21. The European Court of Human Rights found a procedural violation of Article 8 in the circumstances.

PMC+1

Application to fertility screening: The case is relevant to the importance of timely reproductive-health information, appropriate medical procedures, and effective decision-making. It supports attention to the procedures through which patients receive relevant information, rather than treating screening as a purely technical matter.

It is not a ruling that every person has an unconditional right to every available fertility test.

Case 8: AB and Another v. Minister of Social Development (2016)

Constitutional Court of South Africa · [2016] ZACC 43

Facts: The case concerned restrictions on access to surrogacy where intended parents could not provide the required genetic link to the child.

Decision: The Constitutional Court invalidated the genetic-link requirement in section 294 of the Children's Act, finding it constitutionally inconsistent. The judgment addressed equality, dignity, reproductive autonomy, and access to healthcare.

SAFLII

Application to fertility screening: This judgment is relevant when screening rules exclude people from reproductive services because they lack a particular genetic characteristic or cannot meet a genetic-link requirement.

It cautions against assuming that a single genetic criterion is necessarily an appropriate measure of parental suitability.

Legal principle: Restrictions on reproductive services must be assessed against constitutional equality, dignity, and reproductive autonomy.

5. Major legal issues in biometric fertility screening

A. Informed consent and bodily autonomy

Consent should be informed, voluntary, and appropriate to the procedure. Patients should understand what is being measured, why the test is proposed, its limitations, and how the results may affect their treatment.

A person agreeing to a blood test does not necessarily consent to genetic sequencing, the creation of a long-term fertility profile, or sharing the results with third parties.

Under section 22 of the Indian ART Act, written consent is required for ART treatment and procedures. The exact consent requirements for a standalone screening test must be assessed under the applicable medical and legal framework.

India Code+1

B. Privacy and confidentiality

Fertility data can reveal sensitive personal circumstances even when a record contains no name. For example, a combination of age, location, genetic results, and treatment dates may make an individual identifiable.

Appropriate safeguards include:

Collecting only information necessary for the specified purpose.

Restricting access to authorised healthcare personnel.

Encrypting and securing stored records.

Establishing retention and deletion policies consistent with applicable law.

Prohibiting unauthorised disclosure to employers or unrelated commercial entities.

Providing appropriate procedures for complaints and data breaches.

Section 21 of the ART Act expressly addresses confidentiality of information concerning patients and donors, subject to specified exceptions.

Indian Kanoon+1

C. Discrimination in employment and insurance

A fertility screening system might classify an employee as having a low probability of conception or a higher likelihood of requiring reproductive treatment.

Using such a classification to deny employment, promotion, insurance benefits, or other opportunities may raise questions of discrimination, privacy, and unlawful use of medical information.

The legal position depends on the relevant legislation and the particular decision. A predictive fertility score is not, by itself, proof of incapacity or a valid reason to exclude someone from an opportunity.

D. Algorithmic bias and scientific reliability

Automated screening systems may produce inaccurate predictions because of limited training data, poorly validated assumptions, or differences between the populations on which the system was tested and the people being assessed.

A fertility prediction can be affected by age, medical history, medications, underlying conditions, and other factors that a particular model may not adequately consider.

Legally responsible systems should provide:

Independent clinical validation.

Clear explanations of uncertainty and limitations.

Human review of consequential decisions.

A mechanism to correct inaccurate records.

An accessible process for challenging an adverse decision.

A model should not turn a statistical estimate into an unsupported categorical judgment that someone is fertile, infertile, or unfit to reproduce.

E. Eugenics and reproductive selection

Fertility screening becomes especially controversial when used to rank people by perceived genetic quality, reproductive desirability, or predicted characteristics of future children.

There is an important legal distinction between screening intended to identify a serious inherited condition and screening intended to enforce social preferences about who should reproduce.

The reasoning in Costa and Pavan v. Italy is relevant to disease-related genetic testing, while Suchita Srivastava supplies an important Indian constitutional foundation for reproductive autonomy. Neither case creates an unlimited right to genetic selection or overrides applicable statutory safeguards.

HUDOC+1

6. Practical application: illustrative legal scenarios

These are hypothetical examples, not findings that a court has decided each scenario. The legal outcome would depend on the facts, applicable statutes, evidence, and available remedies.

7. Regulatory and institutional accountability

A responsible legal framework for biometric fertility screening should assign clear duties to the institutions that collect, interpret, store, and use the data.

Clinical accountability

Clinics should document the medical reason for testing, explain the limits of the results, obtain appropriate consent, and ensure qualified interpretation.

Data accountability

Organisations should document the purpose of collection, control access, secure records, and comply with applicable data-protection and confidentiality requirements.

Equality and rights review

Institutions should examine whether screening is necessary, whether less intrusive alternatives exist, and whether the results are being used to make unjustified decisions.

Independent review and remedies

Patients should have appropriate channels to challenge inaccurate results, report misuse, seek correction, and pursue remedies under the applicable law.

The Digital Personal Data Protection Act, 2023 and the Digital Personal Data Protection Rules, 2025 form part of India's evolving data-protection framework. However, their commencement is phased, so the provisions actually in force at the time of a particular screening or disclosure must be checked.

Press Information Bureau+2

8. Critical analysis

The central difficulty is that fertility screening can serve legitimate medical purposes while also creating opportunities for surveillance and discrimination.

A clinically validated test may help a patient understand reproductive options, identify a medical condition, or make informed decisions about treatment. The same information can cause harm if it is disclosed without authority, interpreted inaccurately, or used to determine someone's employment prospects or social status.

Three distinctions are particularly important:

Medical information versus social judgment: A fertility marker is a clinical indicator, not a measure of a person's worth or suitability for parenthood.

Voluntary screening versus coercive testing: Offering a test for an informed medical purpose differs substantially from compelling a person to undergo testing without adequate justification.

Clinical prediction versus legal determination: An algorithm's prediction cannot automatically substitute for individual assessment, lawful decision-making, and procedural fairness.

The case law discussed above provides established principles for evaluating these risks, but there is no single Supreme Court of India judgment that comprehensively establishes a separate doctrine specifically called Biometric Fertility Screening Law.

9. Conclusion

Biometric fertility screening sits at the intersection of reproductive medicine, privacy, technology, and human rights. Its legality cannot be determined solely by asking whether the technology can measure or predict a reproductive characteristic. The more important questions concern why the test is being performed, whether it is scientifically reliable, whether appropriate consent and legal authority exist, and how the resulting information will be used.

In India, Puttaswamy, Suchita Srivastava, and Neera Mathur provide important foundations for privacy, reproductive autonomy, and protection against intrusive reproductive-health disclosure. The ART Act, 2021 supplies additional statutory duties where assisted reproduction is involved. Decisions such as Evans, Costa and Pavan, and AB v. Minister of Social Development provide comparative perspectives on reproductive consent, genetic testing, equality, and access to reproductive services.

The governing legal principle is that fertility screening should support informed healthcare decisions rather than become a mechanism for coercion, unjustified surveillance, or reproductive discrimination.